Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patients
Date
Authors
Lutzky, Viviana P
Davis, Joanne E
Crooks, Pauline
Corban, Monika
Smith, Mark C
Elliott, Michael
Morrison, Leanne E.
Cross, Simone
Tscharke, David
Panizza, Benedict
Journal Title
Journal ISSN
Volume Title
Publisher
Blackwell Publishing Ltd
Abstract
Nasopharyngeal carcinoma (NPC) is Epstein-Barr virus (EBV) positive in all undifferentiated cases, expressing the latency II phenotype of latent membrane proteins (LMPs) 1 and 2, in addition to EBV nuclear antigen (EBNA) 1. Several studies have attempted
Description
Citation
Collections
Source
Immunology and Cell Biology
Type
Book Title
Entity type
Access Statement
License Rights
Restricted until
2037-12-31
Downloads
File
Description